Latest Articles

Publication Date
Advancing Precision: The Vital Role of Biomarker Testing in Endometrial Cancer - Targeted Oncology

Advancing Precision: The Vital Role of Biomarker Testing in Endometrial Cancer Targeted Oncology

Published: Feb. 6, 2026, 10:05 p.m.
How Does Rina-S Work in Patients With Pretreated Endometrial Cancer? - Oncology Nursing News

How Does Rina-S Work in Patients With Pretreated Endometrial Cancer? Oncology Nursing News

Published: Feb. 5, 2026, 5:03 p.m.
GSK’s Jemperli Wins Public Reimbursement in Quebec for Endometrial Cancer Indication - NAVLIN DAILY

GSK’s Jemperli Wins Public Reimbursement in Quebec for Endometrial Cancer Indication NAVLIN DAILY

Published: Feb. 5, 2026, 3:44 a.m.
Inoperable To Cancer-Free: Medanta Doctors Achieve Rare Complete Response In Advanced Endometrial Cancer - BW Healthcare World

Inoperable To Cancer-Free: Medanta Doctors Achieve Rare Complete Response In Advanced Endometrial Cancer BW Healthcare World

Published: Feb. 4, 2026, 7:56 a.m.
Quebec first province to publicly reimburse Jemperli (dostarlimab for injection) plus chemotherapy via RAMQ for the treatment of all adult patients with primary advanced or first recurrent endometrial cancer - BioSpace

Quebec first province to publicly reimburse Jemperli (dostarlimab for injection) plus chemotherapy via RAMQ for the treatment of all adult patients with primary advanced or first recurrent endometrial cancer BioSpace

Published: Feb. 4, 2026, 4:47 a.m.
Gsk - Quebec To Reimburse Jemperli Plus Chemotherapy Via Ramq For Primary Advanced/First Recurrent Endometrial Cancer - TradingView

Gsk - Quebec To Reimburse Jemperli Plus Chemotherapy Via Ramq For Primary Advanced/First Recurrent Endometrial Cancer TradingView

Published: Feb. 3, 2026, 1:11 p.m.
Why Endometrial Cancer Is Rising Among Younger Women And What Doctors Want You To Know - News18

Why Endometrial Cancer Is Rising Among Younger Women And What Doctors Want You To Know News18

Published: Feb. 3, 2026, 1:06 p.m.
Quebec first province to publicly reimburse Jemperli (dostarlimab for injection) plus chemotherapy via RAMQ for the treatment of all adult patients with primary advanced or first recurrent endometrial cancer - Newswire Canada

Quebec first province to publicly reimburse Jemperli (dostarlimab for injection) plus chemotherapy via RAMQ for the treatment of all adult patients with primary advanced or first recurrent endometrial cancer Newswire …

Published: Feb. 3, 2026, 1 p.m.
Quebec first province to publicly reimburse Jemperli (dostarlimab for injection) plus chemotherapy via RAMQ for the treatment of all adult patients with primary advanced or first recurrent endometrial cancer - Yahoo Finance Singapore

Quebec first province to publicly reimburse Jemperli (dostarlimab for injection) plus chemotherapy via RAMQ for the treatment of all adult patients with primary advanced or first recurrent endometrial cancer Yahoo …

Published: Feb. 3, 2026, 1 p.m.
How Patients Define Treatment Options in Endometrial Cancer Trials - Medscape

How Patients Define Treatment Options in Endometrial Cancer Trials Medscape

Published: Feb. 2, 2026, 7:08 p.m.
Link copied to clipboard!
Subscribe to Our Newsletter

Stay updated with our latest articles!